Circulating levels of matrix metalloproteinases in heart transplant recipients.
Dorent
R
R
Service de Chirurgie Cardio-Vasculaire et Thoracique, Hôpital Pitié-Salpêtrière, Paris, France.
Beaudeux
J L
JL
Tezenas
S
S
Ghossoub
J J
JJ
Roussouliere
A L
AL
Leger
P
P
Vaissier
E
E
Bonnet
N
N
Leprince
P
P
Regan
M
M
Pavie
A
A
Foglietti
M J
MJ
Cacoub
P
P
Gandjbakhch
I
I
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D005260:Female; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use; D008297:Male; D020781:Matrix Metalloproteinase 1 / Q000097:blood; D019278:Matrix Metalloproteinase 3 / Q000097:blood; D020782:Matrix Metalloproteinases / Q000097:blood*; D008875:Middle Aged; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000097:blood; D014280:Triglycerides / Q000097:blood
D007166:Immunosuppressive Agents; D014280:Triglycerides; D019716:Tissue Inhibitor of Metalloproteinase-2; D016572:Cyclosporine; D002784:Cholesterol; D003404:Creatinine; D020782:Matrix Metalloproteinases; D019278:Matrix Metalloproteinase 3; D020781:Matrix Metalloproteinase 1